Polyvinyl alcohol (PVA), also called polyvinyl alcohol polymer or PVOH, is a synthetic, water-soluble polymer used in pharmaceutical, ophthalmic, food, cosmetic, and industrial products. In medicine, it is most commonly used as an ophthalmic lubricant for the temporary relief of dry, burning, or irritated eyes.
Unlike many conventional active pharmaceutical ingredients, polyvinyl alcohol is a polymer rather than a small, discrete molecule. Its properties depend on molecular weight, degree of hydrolysis, viscosity, and residual acetate content. Pharmaceutical-grade PVA is manufactured to meet appropriate quality, purity, and microbiological standards. Its CAS number is 9002-89-5, and its repeating-unit formula is commonly represented as .
Chemical Structure
Polyvinyl alcohol consists of repeating vinyl alcohol units containing hydroxyl groups along a carbon-chain backbone. Because vinyl alcohol is unstable in its isolated form, PVA is generally manufactured by polymerizing vinyl acetate and then hydrolyzing or alcoholizing the resulting polyvinyl acetate.
The extent of hydrolysis affects water solubility, viscosity, crystallinity, and film-forming behavior. Partially hydrolyzed grades retain some acetate groups and are often more readily water-soluble, whereas highly hydrolyzed grades may form stronger films and have different dissolution characteristics. These variations are important when selecting a grade for eye drops or other pharmaceutical applications.
PVA is hydrophilic and can form a thin, moisture-retaining film on epithelial surfaces. In ophthalmic products, this allows it to increase lubrication and reduce friction between the eyelid and ocular surface.

Polyvinyl Alcohol-Based Medicines: Top Eight
Examples of products containing polyvinyl alcohol include:
- Polyvinyl Alcohol Ophthalmic Solution 1.4%.
- Polyvinyl Alcohol Ophthalmic Solution 0.5%.
- Artificial Tears containing polyvinyl alcohol.
- Refresh Classic, containing polyvinyl alcohol and povidone.
- Polyvinyl alcohol–povidone ophthalmic drops.
- Preservative-free polyvinyl alcohol ophthalmic drops.
- Generic polyvinyl alcohol lubricant eye drops.
- Combination artificial-tear products containing polyvinyl alcohol with povidone or other lubricants.
Product names and concentrations vary by country. Some products are prescription medicines, while many eye-lubricant preparations are sold over the counter. DailyMed listings include polyvinyl alcohol ophthalmic solutions at concentrations such as 1.4% and 0.5%.
Mechanism of Action
Polyvinyl alcohol acts mainly as a physical lubricant rather than a pharmacologically active receptor-targeting drug. When placed in the eye, its hydrophilic polymer chains spread across the ocular surface and help retain moisture.
The polymer increases the persistence and stability of the tear film, reduces friction during blinking, and temporarily relieves dryness, burning, irritation, and foreign-body sensations. It may also provide a protective layer against further irritation caused by wind, sunlight, heating, air conditioning, or prolonged visual tasks.
PVA does not treat the underlying cause of inflammatory, infectious, allergic, or structural eye disease. It is therefore considered a supportive lubricant rather than a curative treatment for serious ocular disorders.
Pharmacokinetics
Systemic pharmacokinetic data for ophthalmic PVA are limited because the polymer is intended to act locally on the eye and has low systemic absorption when used as directed. A portion of an eye drop is removed through blinking and the nasolacrimal drainage system, while another portion remains temporarily on the ocular surface.
The ophthalmic residence time is short, and one reference reports an estimated ocular half-life of approximately 7.2 minutes. Pharmacokinetics vary with molecular weight, concentration, viscosity, formulation, and the presence of other polymers.
PVA is not substantially metabolized in the eye. Small amounts that pass through the nasolacrimal duct may be swallowed, but clinically significant systemic exposure is not expected from ordinary ophthalmic use. This limited absorption helps explain why drug interactions are uncommon.
Therapeutic Uses
| Therapeutic use | Role of polyvinyl alcohol | Typical product use |
|---|---|---|
| Dry-eye symptoms | Lubricates and moistens the ocular surface | Instill one or two drops as needed |
| Burning and irritation | Provides temporary symptomatic relief | Used for minor irritation |
| Wind or sun exposure | Helps protect against further dryness and irritation | Used after environmental exposure |
| Computer-related eye discomfort | Supports tear-film lubrication | Used as needed during prolonged screen use |
| Contact-lens-related dryness | May relieve symptoms with appropriate formulation | Contact lenses may need removal before use |
| Postoperative or medication-related dryness | Provides supportive lubrication | Used only when approved by an eye-care professional |
| Mild foreign-body sensation | Reduces surface friction | Does not replace evaluation of an actual foreign body |
| Combination artificial tears | Contributes lubrication with povidone or other polymers | Used according to product instructions |
Most over-the-counter labels recommend one or two drops in the affected eye or eyes as needed. The exact dose depends on the concentration and formulation.
Side Effects
“Polyvinyl alcohol” ophthalmic products are generally well tolerated. Temporary blurred vision may occur immediately after instillation, particularly with more viscous formulations. Mild stinging, burning, irritation, itching, redness, increased tearing, eyelid crusting, or a foreign-body sensation may also occur.
Serious allergic reactions are rare but may cause facial swelling, rash, severe itching, dizziness, or difficulty breathing. These symptoms require urgent medical attention.
Persistent eye pain, vision changes, continued redness, or worsening irritation should not be attributed automatically to dry eye. U.S. product labels advise stopping use and seeking medical advice if symptoms persist or worsen for more than 72 hours.
Drug Interactions
Polyvinyl alcohol has no well-established systemic drug interactions when used as an ophthalmic lubricant. However, it may physically interfere with other eye drops if several products are instilled together.
When multiple ophthalmic medicines are needed, they should generally be administered several minutes apart, following professional advice. Ointments are usually applied after aqueous eye drops because they can interfere with absorption of subsequently administered solutions.
Some products contain preservatives or additional active ingredients. Patients with preservative sensitivity, frequent dosing requirements, or ocular-surface disease may need preservative-free formulations.
Safety Considerations
Polyvinyl alcohol eye drops should not be used if the solution becomes cloudy, changes color, or shows visible particles. The dropper tip should not touch the eye, eyelid, fingers, or other surfaces because contamination can cause eye infection. Containers should be closed immediately after use and stored according to the package instructions.
Contact lenses should generally be removed before using preserved eye drops and replaced only after the interval stated on the label. Some products are compatible with contact lenses, but this must be confirmed from the specific product information.
PVA ophthalmic products should not be used to self-treat severe eye pain, sudden vision loss, chemical injury, penetrating injury, or suspected infection. Children, pregnant patients, and breastfeeding patients should follow product labeling and seek professional advice when prolonged use is required.

Regulatory Status
Polyvinyl alcohol is used in pharmaceutical products as an ophthalmic active lubricant and as an excipient in selected formulations. In the United States, certain PVA ophthalmic solutions are marketed as over-the-counter eye lubricants under applicable FDA requirements. DailyMed records identify products containing polyvinyl alcohol at concentrations including 1.4% and 0.5%.
The polymer is also recognized in pharmaceutical and food regulatory contexts, but regulatory status depends on grade, purity, route of administration, concentration, intended use, and country. Approval of one ophthalmic product does not automatically authorize every PVA grade or formulation for human use.
Conclusion
Polyvinyl alcohol is a hydrophilic synthetic polymer widely used in artificial tears and other pharmaceutical products. Its principal medical function is physical lubrication of the ocular surface, helping relieve temporary dryness, burning, irritation, and discomfort. It has minimal systemic absorption and few recognized drug interactions, but contaminated products, persistent symptoms, severe pain, or visual changes require medical evaluation. Product-specific instructions should always be followed.











